Zobrazeno 1 - 10
of 39
pro vyhledávání: '"AM Gutierrez Barrera"'
Publikováno v:
Cancer Research. 78:PD1-10
Background: Every woman diagnosed with breast cancer has a risk to develop another breast primary throughout their lifetime. This risk is significantly elevated in individuals with a BRCA1 or BRCA2 mutation. For these individuals, the risk of a secon
Autor:
Banu Arun, Nisreen Elsayegh, AM Gutierrez Barrera, Jennifer K. Litton, Henry Mark Kuerer, ND Hernandez
Publikováno v:
Cancer Research. 77:P2-07
Background: Availability of multiplex gene (MPG) testing for hereditary cancer has led to increase use of panel testing versus single gene testing for hereditary cancer. These panels include high, but also moderate penetrance genes. For some of these
Publikováno v:
Cancer Research. 78:P3-04
Background: TP53 and PIK3CA are the most frequently mutated genes in breast cancer. However, there is limited data evaluating the impact of somatic mutations in TP53 and/or PIK3CA patients (pts) with metastatic breast cancer (MBC) who have undergone
Autor:
Giovana Tardin Torrezan, Edenir Inêz Palmero, Henrique de Campos Reis Galvão, C. M. Berra, FT de Lima, MN da Cruz Formiga, Gabriela C Fernandes, Rafael Canfield Brianese, B. K. Arun, AE de Paula, Dirce Maria Carraro, AM Gutierrez Barrera, Rodrigo Augusto Depieri Michelli
Publikováno v:
Cancer Research. 79:P4-03
This abstract was not presented at the conference. Citation Format: Carraro DM, Palmero EI, Galvao HC, Berra CM, Brianese RC, Torrezan GT, da Cruz Formiga MN, de Lima FT, Fernandes GC, de Paula AE, Michelli RD, Gutierrez Barrera AM, Arun BK. Not pres
Autor:
Jennifer K. Litton, Nisreen Elsayegh, Henry Mark Kuerer, Soley Bayraktar, Gabriel N. Hortobagyi, Banu Arun, AM Gutierrez Barrera, Kimberly I. Muse, Constance Albarracin, Tunc Tasbas, Funda Meric-Bernstam, Heather Lin, Kaylene Ready
Publikováno v:
Cancer. 120:927-927
Autor:
K. K. Hunt, Gildy Babiera, AM Gutierrez Barrera, Elizabeth A. Mittendorf, Isabelle Bedrosian, Banu Arun, Funda Meric-Bernstam, Min Yi, Henry Mark Kuerer
Publikováno v:
Journal of Clinical Oncology. 27:1528-1528
1528 Background: Women with breast cancer have an increased risk of developing contralateral breast cancer in their lifetime. Thus increasing numbers of women have been electing to undergo contralateral prophylactic mastectomy (CPM) at the time of th
Autor:
Nguyen NH; The University of Texas MD Anderson Cancer Center, Department of Bioinformatics and Computation Biology, Houston, TX.; Rice University, Department of Statistics, Houston, TX., Dodd-Eaton EB; The University of Texas MD Anderson Cancer Center, Department of Bioinformatics and Computation Biology, Houston, TX., Corredor JL; The University of Texas MD Anderson Cancer Center, Department of Clinical Cancer Genetics, Houston, TX., Woodman-Ross J; The University of Texas MD Anderson Cancer Center, Department of Clinical Cancer Genetics, Houston, TX., Green S; The University of Texas MD Anderson Cancer Center, Department of Clinical Cancer Genetics, Houston, TX., Hernandez ND; The University of Texas MD Anderson Cancer Center, Department of Clinical Cancer Genetics, Houston, TX., Gutierrez Barrera AM; The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX., Arun BK; The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX., Wang W; The University of Texas MD Anderson Cancer Center, Department of Bioinformatics and Computation Biology, Houston, TX.
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2023 Sep 02. Date of Electronic Publication: 2023 Sep 02.
Autor:
Murphy BL; Department of Surgical Oncology, Banner MD Anderson Cancer Center, Phoenix, AZ, USA., Yi M; Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gutierrez Barrera AM; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tripathy D; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hunt KK; Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Arun BK; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. barun@mdanderson.org.; Department of Clinical Cancer Genetics, University of Texas MD Anderson Cancer Center, Houston, TX, USA. barun@mdanderson.org.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2023 Mar; Vol. 30 (3), pp. 1663-1668. Date of Electronic Publication: 2022 Sep 12.
Autor:
Makhnoon S; Department of Behavioral Science, UT MD Anderson Cancer Center, Houston, TX, USA., Gutierrez Barrera AM; Department of Breast Medical Oncology Research, UT MD Anderson Cancer Center, Houston, TX, USA., Bassett R; Department of Biostatistics, UT MD Anderson Cancer Center, Houston, TX, USA., Afrough A; Department of Internal Medicine, Hematology/Oncology, UT Southwestern Medical Center, Dallas, TX, USA., Bedrosian I; Department of Breast Surgical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA., Arun BK; Department of Breast Medical Oncology Research, UT MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
The breast journal [Breast J] 2022 Dec 31; Vol. 2022, pp. 1447545. Date of Electronic Publication: 2022 Dec 31 (Print Publication: 2022).
Autor:
Garber HR; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Raghavendra AS; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Lehner M; Departments of UT Internal Medicine Residency Training Program, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Qiao W; Departments of Biostatistics, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Gutierrez-Barrera AM; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Tripathy D; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Arun B; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA., Ibrahim NK; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. nibrahim@mdanderson.org.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2022 Apr 07; Vol. 8 (1), pp. 46. Date of Electronic Publication: 2022 Apr 07.